Psyence Biomedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021
Cash & Equivalents	0.13	0.65
Cash & Cash Equivalents	0.13	0.65
Cash Growth	-80.15%	-
Other Current Assets	1.08	0.32
Total Current Assets	1.21	0.97
Long-Term Investments	257.73	255
Other Long-Term Assets	0	0.25
Total Long-Term Assets	257.73	255.25
Total Assets	258.93	256.22
Accounts Payable	0.52	0.07
Other Current Liabilities	13.75	0
Total Current Liabilities	14.27	0.07
Other Long-Term Liabilities	258.55	19.51
Total Long-Term Liabilities	258.55	19.51
Total Liabilities	272.83	19.58
Retained Earnings	-13.9	-18.36
Shareholders' Equity	-13.89	-18.35
Net Cash / Debt	0.13	0.65
Net Cash / Debt Growth	-80.15%	-
Net Cash Per Share	0.00	0.05
Working Capital	-13.07	0.9
Book Value Per Share	-0.42	-1.44

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).